BRUSSELS – “We keep our promises. The European Commission has closed the first agreement to purchase up to 400 million doses of the future vaccine against the Covid-19“So the president of the Community Executive, Ursula von der Leyen, on Twitter. “We are committed to safeguarding the health of Europeans and our global partners,” adds the president.
The news follows that relating to exploratory talks undertaken with Sanofi-Gsk, announced on July 31, and with Johnson & Johnson yesterday. Once the vaccine proves safe and effective against the virus, the Commission will have the ability to purchase 300 million doses of the vaccine AstraZeneca, with an option to purchase an additional 100 million, on behalf of the Member States.
The Commission, he points out, continues to discuss similar agreements with other vaccine manufacturers. The deal approved today will be funded through the Emergency Support Instrument, which has funds dedicated to creating a portfolio of potential vaccines with different profiles and products from different companies.
–
